Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
Paul E. Verweij, Roger J. M. Brüggemann, Élie Azoulay, et al.
Intensive Care Medicine (2021) Vol. 47, Iss. 8, pp. 819-834
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

COVID-19-associated fungal infections
Martin Hoenigl, Danila Seidel, Rosanne Sprute, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1127-1140
Open Access | Times Cited: 327
ESCMID COVID-19 living guidelines: drug treatment and clinical management
Michele Bartoletti, Özlem Kurt Azap, Aleksandra Barać, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 222-238
Open Access | Times Cited: 139
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India
Valliappan Muthu, Ritesh Agarwal, Atul Patel, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 9, pp. e240-e253
Open Access | Times Cited: 67
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
Matteo Bassetti, Daniele Roberto Giacobbe, Christina Agvald‐Öhman, et al.
Intensive Care Medicine (2024) Vol. 50, Iss. 4, pp. 502-515
Open Access | Times Cited: 39
ICU-acquired infections in immunocompromised patients
Louis Kreitmann, Julie Helms, Ignacio Martín‐Loeches, et al.
Intensive Care Medicine (2024) Vol. 50, Iss. 3, pp. 332-349
Closed Access | Times Cited: 24
A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
Simon Feys, Maria Panagiota Almyroudi, Reinout Braspenning, et al.
Journal of Fungi (2021) Vol. 7, Iss. 12, pp. 1067-1067
Open Access | Times Cited: 77
Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study
Anahita Rouzé, Elise Lemaître, Ignacio Martín‐Loeches, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 57
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
Rasmus Leistner, Lisa Schroeter, Thomas C. Adam, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 56
Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set
Andrew Conway Morris, Katharina Köhler, Thomas De Corte, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 44
Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance
Carter Merenstein, Frederic D. Bushman, Ronald G. Collman
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 43
Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?
Sarah Dellière, Emmanuel Dudoignon, Sébastian Voicu, et al.
Journal of Clinical Microbiology (2022) Vol. 60, Iss. 3
Open Access | Times Cited: 41
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
Matthias Egger, Linda Bussini, Martin Hoenigl, et al.
Journal of Fungi (2022) Vol. 8, Iss. 4, pp. 390-390
Open Access | Times Cited: 40
Acute kidney injury in critical COVID-19: a multicenter cohort analysis in seven large hospitals in Belgium
Hannah Schaubroeck, Wim Vandenberghe, Willem Boer, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 40
The changing epidemiology of fungal infections
Cornelia Lass‐Flörl, Stephan Steixner
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101215-101215
Open Access | Times Cited: 38
Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients
Simon Feys, Agostinho Carvalho, Cornelius J. Clancy, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 9, pp. 728-742
Closed Access | Times Cited: 12
Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis/aspergillus tracheobronchitis
Sofie Van Ackerbroeck, Lynn Rutsaert, Ella Roelant, et al.
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 44
COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave
Stéphane Bretagne, Karine Sitbon, Françoise Botterel, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 40
COVID‐19‐associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID‐19 patients
Jorge Calderón‐Parra, Patricia Mills-Sánchez, Víctor Moreno‐Torres, et al.
Mycoses (2022) Vol. 65, Iss. 5, pp. 541-550
Open Access | Times Cited: 32
Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy
Rebecca van Grootveld, Martha T. van der Beek, Nico Janssen, et al.
Journal of Critical Care (2023) Vol. 76, pp. 154272-154272
Open Access | Times Cited: 16
Point-of-care testing for viral-associated pulmonary aspergillosis
Robina Aerts, Brice Autier, Maximilian Gornicec, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 24, Iss. 3, pp. 231-243
Open Access | Times Cited: 16
Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment
Jannes Heylen, Yuri Vanbiervliet, Johan Maertens, et al.
Seminars in Respiratory and Critical Care Medicine (2024) Vol. 45, Iss. 01, pp. 069-087
Open Access | Times Cited: 6
Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit
Alessandra Iacovelli, Alessandra Oliva, Flavio Marco Mirabelli, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Severe mold fungal infections in critically ill patients with COVID-19
Despoina Koulenti, Elisabeth Paramythiotou, Maria Panagiota Almyroudi, et al.
Future Microbiology (2024) Vol. 19, Iss. 9, pp. 825-840
Open Access | Times Cited: 5
Treatment of Post-COVID-19 Pulmonary Aspergilloma: Insights from a Clinical Case
Atif Saleem Siddiqui
American Journal of Case Reports (2025) Vol. 26
Open Access
Epidemiology of Coronavirus Disease 2019-Associated Fungal Infections in the Intensive Care Unit: A Single-Center Retrospective Study
Jessica S Little, Gerald McGwin, Lisa A Tushla, et al.
Mycopathologia (2025) Vol. 190, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top